BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 19433066)

  • 21. The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma.
    Kumar A; Fillmore HL; Kadian R; Broaddus WC; Tye GW; Van Meter TE
    Mol Cancer Res; 2009 Nov; 7(11):1813-21. PubMed ID: 19887560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribotoxic mycotoxin deoxynivalenol induces G2/M cell cycle arrest via p21Cip/WAF1 mRNA stabilization in human epithelial cells.
    Yang H; Chung DH; Kim YB; Choi YH; Moon Y
    Toxicology; 2008 Jan; 243(1-2):145-54. PubMed ID: 18006205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.
    Hill KM; Kalifa S; Das JR; Bhatti T; Gay M; Williams D; Taliferro-Smith L; De Marzo AM
    Prostate; 2010 May; 70(7):755-64. PubMed ID: 20058239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of inhibiting proliferation of human ovarian cancer cells of the line HO-8910 by dexamethasone: the role of RhoB signaling pathway].
    Chen YX; Li ZB; Diao F; Wang Y; Lu J
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(20):1400-4. PubMed ID: 16796923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility for NSAIDs-induced apoptosis correlates to p53 gene status in gastric cancer cells.
    Zhang YJ; Dai Q; Wu SM; Zhu HY; Shen GF; Li EL; Xiao SD
    Cancer Invest; 2008 Nov; 26(9):868-77. PubMed ID: 18798056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
    Ni J; Wen X; Yao J; Chang HC; Yin Y; Zhang M; Xie S; Chen M; Simons B; Chang P; di Sant'Agnese A; Messing EM; Yeh S
    Cancer Res; 2005 Nov; 65(21):9807-16. PubMed ID: 16267002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
    Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
    Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C
    J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
    Guo D; Ye J; Dai J; Li L; Chen F; Ma D; Ji C
    Leuk Res; 2009 May; 33(5):678-85. PubMed ID: 19091404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
    Lee TK; Stupans I
    J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assay development for high throughput screening of p21(Waf1/Cip1) protein expression in intact cells using fluorometric microvolume assay technology.
    Grand-Perret T; Cik M; Arts J; Vander Borght A; Ercken M; Valckx A; Vermeesen A; Roevens R; Janicot M
    Drugs Exp Clin Res; 2004; 30(3):89-98. PubMed ID: 15366785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 response to arsenic exposure in epithelial cells: protein kinase B/Akt involvement.
    Sandoval M; Morales M; Tapia R; del Carmen Alarcón L; Sordo M; Ostrosky-Wegman P; Ortega A; López-Bayghen E
    Toxicol Sci; 2007 Sep; 99(1):126-40. PubMed ID: 17567589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog.
    Mujoo K; Watanabe M; Khokhar AR; Siddik ZH
    Prostate; 2005 Jan; 62(1):91-100. PubMed ID: 15389812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
    Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
    Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase.
    Zemskova M; Wechter W; Bashkirova S; Chen CS; Reiter R; Lilly MB
    Biochem Pharmacol; 2006 Nov; 72(10):1257-67. PubMed ID: 16949054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
    J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.